76
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assessment of Long-Term Effects on Pulmonary Functions Between Severe and Non-Severe Convalescent COVID-19 Patients: A Single-Center Study in China

, , , , , , , & show all
Pages 4751-4761 | Published online: 19 Aug 2022

References

  • Sigfrid L, Cevik M, Jesudason E, et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study. BMJ Open. 2021;11:e043887. doi:10.1101/2020.08.26.20180950
  • Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021. doi:10.1101/2021.01.27.21250617
  • Cheung OY, Chan JWM, Ng CK, Koo CK. The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology. 2004;45(2):119–124. doi:10.1111/j.1365-2559.2004.01926.x
  • Lindsay McDonald T. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320(2):L257–L265. doi:10.1152/ajplung.00238.2020
  • Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Medical science monitor. Int J Clin Exp Med. 2020;26:e928996. doi:10.12659/MSM.928996
  • Zhao X, Nicholls JM, Chen YG. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling. J Biol Chem. 2008;283(6):3272–3280. doi:10.1074/jbc.M7080.33200
  • Lal SK. Molecular biology of the SARS-coronavirus. Springer. 2010;1–328. doi:10.1007/978-3-642-03683-5
  • Lingyan Y, Yao G, Lin S, et al. The investigation of pulmonary function changes of COVID-19 patients in three months. J Healthc Eng. 2022;2022:9028835. doi:10.1155/2022/9028835
  • Long QY, Li JW, Hu XY, et al.Follow-ups on persistent symptoms and pulmonary function among post-acute COVID-19 patients: a systematic review and meta-analysis. Front med. 2021;8:702635. doi:10.3389/fmed.2021.702635
  • Balasubramanian A, MacIntyre NR, Henderson RJ, et al. Diffusing capacity of carbon monoxide in the assessment of COPD. Chest. 2019;156:1111–1119. doi:10.1016/j.chest.2019.06.035
  • Gattinoni L, Marini JJ, Busana M, et al. Spontaneous breathing, transpulmonary pressure and mathematical trickery. Ann Intensive Care. 2020;10(1):1–2. doi:10.1186/s13613-020-00708-1
  • Tobin MJ, Laghi F, Jubran A. Caution about early intubation and mechanical ventilation in COVID-19. Ann Intensive Care. 2020;10(1):4–6. doi:10.1186/s13613-020-00692-6
  • Lerum TV, Aaløkken TM, Bronstad E, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Res J. 2021;57(4). doi:10.1183/13993003.03448-2020
  • Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi:10.1016/S0140-6736(20)32656-8
  • Xiaojun W, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Res Med. 2021;9(7):747–754. doi:10.1016/S2213-2600(21)00174-0
  • Huang L, Yao Q, Xiaoying G, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747–758. doi:10.1016/S0140-6736(21)01755-4
  • Zhi H, Xiaolong J, Zhao Z, et al. Risk factors for impaired pulmonary diffusion function in convalescent COVID-19 patients: a systematic review and meta-analysis. E Clin Med. 2022;49:101473. doi:10.1016/j.eclinm.2022.101473
  • Clinical management of severe acute respiratory infection when COVID-19 is suspected. World Health Organization; 2020. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is- suspected. Accessed August 3, 2022.
  • General Office of National Health Commission of the People’s Republic of China. Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment of coronavirus disease-19 (8th trial edition). China Med. 2020;15(10):1494–1499. Chinese.
  • Meiling J, Yuanlin S, Jinping Z, et al. Guideline for pulmonary function testing in primary care (2018). Chinese J Gen Pract. 2019;18(6):511–518.
  • Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70–88. doi:10.1164/rccm.201908-1590ST
  • Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and health status. Respirology. 2010;15(3):543–550. doi:10.1111/j.1440-1843.2010.01720.x
  • Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401–409. doi:10.1136/thx.2004.030205
  • Xie L, Liu Y, Xiao Y, et al. Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge. Chest. 2005;127(6):2119–2124. doi:10.1378/chest.127.6.2119
  • Park WB, Jun KI, Kim G, et al. Correlation between pneumonia severity and pulmonary complications in middle east respiratory syndrome. J Korean Med Sci. 2018;33(24):e169. doi:10.3346/jkms.2018.33.e169
  • Der Brugge SS, Stalman L, Winter B, et al. Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir Med. 2021;176:106272. doi:10.1016/j.rmed.2020.106272
  • Xiaoneng M, Jian W, Zhuquan S, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55(6). doi:10.1183/13993003.01217-2020
  • Guler SA, Ebner L, Aubry-Beigelman C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57(4). doi:10.1183/13993003.03690-2020
  • Chen M, Liu J, Peng P, et al. Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months. E Clin Med. 2022;43:101255. doi:10.1016/j.eclinm.2021.101255
  • Wang Y, Dong C, Hu Y, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;296(2):E55–E64. doi:10.1148/radiol.2020200843
  • Dai H, Zhang X, Xia J, et al. High-resolution chest CT features and clinical characteristics of patients infected with COVID-19 in Jiangsu, China. Int J Infect Dis. 2020;95:106–112. doi:10.1016/j.ijid.2020.04.003
  • Zhe X, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Res Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
  • Zhao Y, Shang Y, Song W-B, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. E Clin Med. 2020;25:100463. doi:10.1016/j.eclinm.2020.100463
  • Zheng Z, Peng F, Buyun X, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25. doi:10.1016/j.jinf.2020.04.021
  • Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26(6):767–772. doi:10.1016/j.cmi.2020.04.012
  • Zhu H, Gaojing Q, Hui Y, et al. Features of α-HBDH in COVID-19 patients: a cohort study. J Clin Lab Anal. 2021;35(1):e23690. doi:10.1002/jcla.23690
  • Shuwa HA, Shaw TN, Knight SB, et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med. 2021;2(6):720–735.e4. doi:10.1016/j.medj.2021.03.013
  • Yan H, Tan Y, Zhuang H, et al. A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS. Zhonghua Jiehe Zazhi. 2006;45(11):896–899.
  • Cesheng L, Ding Y, Xiao W, et al. Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. Nat Commun. 2021;12(1):4144. doi:10.1038/s41467-021-24230-5
  • Isho B, Abe KT, Zuo M, et al. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Sci Immunol. 2020;5(52). doi:10.1126/sciimmunol.abe5511
  • Zhang X, Suwen L, Hui L, et al. Viral and antibody kinetics of COVID-19 patients with different disease severities in acute and convalescent phases: a 6-month follow-up study. Virol Sin. 2020;35(6):820–829. doi:10.1007/s12250-020-00329-9
  • Jackson Turner S, Jane A, Kalaidina E, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal center responses. Nature. 2021;596(7870):109–113. doi:10.1038/s41586-021-03738-2